Literature DB >> 10671934

Recurrence following curative resection for gastric carcinoma.

C H Yoo1, S H Noh, D W Shin, S H Choi, J S Min.   

Abstract

BACKGROUND: The diagnosis and treatment of recurrent gastric cancer remains difficult. The aim of this study was to determine the risk factors for recurrence of gastric cancer and the prognosis for these patients.
METHODS: Of 2328 patients who underwent curative resection for gastric cancer from 1987 to 1995, 508 whose recurrence was confirmed by clinical examination or reoperation were studied retrospectively. The risk factors that determined the recurrence patterns and timing were investigated by univariate and multivariate analysis.
RESULTS: The mean time to recurrence was 21.8 months and peritoneal recurrence was the most frequent (45.9 per cent). Logistic regression analysis showed that serosal invasion and lymph node metastasis were risk factors for all recurrence patterns and early recurrence (at 24 months or less). In addition, independent risk factors involved in each recurrence pattern included younger age, infiltrative or diffuse type, undifferentiated tumour and total gastrectomy for peritoneal recurrence; older age and larger tumour size for disseminated, haematogenous recurrence; and older age, larger tumour size, infiltrative or diffuse type, proximally located tumour and subtotal gastrectomy for locoregional recurrence. Other risk factors for early recurrence were infiltrative or diffuse type and total gastrectomy. Reoperation for cure was possible in only 19 patients and the mean survival time after conservative treatment or palliative operation was less than 12 months.
CONCLUSION: The risk factors for each recurrence pattern and timing of gastric cancer can be predicted by the clinicopathological features of the primary tumour. Since the results of treatment remain dismal, studies of perioperative adjuvant therapy in an attempt to reduce recurrence are warranted.

Entities:  

Mesh:

Year:  2000        PMID: 10671934     DOI: 10.1046/j.1365-2168.2000.01360.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  269 in total

1.  Clinicopathological analysis of patients with gastric cancer in 1200 cases.

Authors:  W X Niu; X Y Qin; H Liu; C P Wang
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

3.  Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study.

Authors:  Do Joong Park; Sang-Uk Han; Woo Jin Hyung; Min Chan Kim; Wook Kim; Seong Yeob Ryu; Seung-Wan Ryu; Kyo Young Song; Hyuk-Joon Lee; Gyu-Seok Cho; Hyung-Ho Kim
Journal:  Surg Endosc       Date:  2011-12-15       Impact factor: 4.584

4.  Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

5.  Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance.

Authors:  I-Rue Lai; Pei-Yu Chu; Hsiao-Sheng Lin; Jun-Yang Liou; Yee-Jee Jan; Jen-Chieh Lee; Tang-Long Shen
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 6.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  The prognostic significance of p53 expression in gastric cancer: a meta-analysis.

Authors:  Kongkong Wei; Lei Jiang; Yaoyao Wei; Yufeng Wang; Xuankun Qian; Qiang Dai; Quanlin Guan
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-15       Impact factor: 4.553

8.  Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.

Authors:  Jing-Ting Jiang; Yue-Ping Shen; Chang-Ping Wu; Yi-Bei Zhu; Wen-Xiang Wei; Lu-Jun Chen; Xiao Zheng; Jing Sun; Bin-Feng Lu; Xue-Guang Zhang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

9.  Short-term outcomes of laparoscopic-assisted distal gastrectomy for gastric cancer during a surgeon's learning curve period.

Authors:  Chang Hak Yoo; Hyung Ook Kim; Sang Il Hwang; Byung Ho Son; Jun Ho Shin; Hungdai Kim
Journal:  Surg Endosc       Date:  2009-01-27       Impact factor: 4.584

10.  Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer.

Authors:  A Díaz de Liaño; C Yárnoz; C Artieda; R Aguilar; S Viana; A Artajona; H Ortiz
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.